Neonatal Coinfection Model of Coagulase-Negative Staphylococcus ( Staphylococcus epidermidis ) and Candida albicans : Fluconazole Prophylaxis Enhances Survival and Growth
Open accessThe DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.
Abstract
Coagulase-negative staphylococci (CoNS) and Candida are among the most common causes of single infections and coinfections in neonates after 72 h of age. In neonates, coinfection increases the rate of mortality threefold and results in significantly greater morbidity compared to those that result from single infections. In an effort to better understand this phenomenon, we developed the first neonatal animal model of coinfection (with CoNS and Candida ) and evaluated its effects on mortality and morbidity and the impact of antifungal prophylaxis with fluconazole. Neonatal Wistar rats were infected with Candida albicans and/or Staphylococcus epidermidis with doses of 2 × 10 8 and 2 × 10 6 CFU subcutaneously in different combinations and were monitored for mortality, weight gain, and bacteremia. The in vitro sensitivity of C. albicans to fluconazole was evaluated and the MIC was determined. A subset of rats in these experiments received fluconazole at 10 mg/kg of body weight/dose intraperitoneally starting 24 h before infection for 4 days, and the serum trough levels of fluconazole were measured. Coinfection in the suckling rat significantly increased the rate of mortality compared to that after infection with a single species ( P < 0.001) and resulted in deaths even at sublethal doses. Coinfection also impaired weight gain significantly in severely infected pups compared to that achieved after infection with a single species ( P < 0.001). Fluconazole prophylaxis significantly reduced mortality by 30% in the Candida group and 36% in the coinfection group and improved weight gain in this neonatal model of coinfection ( P < 0.001). We developed a neonatal model of coinfection with Candida and CoNS, observed significantly greater mortality and morbidity with coinfection, and found that fluconazole prophylaxis significantly reduced the rates of both mortality and morbidity. Further research on neonatal coinfection is urgently needed to improve clinical outcomes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Fluconazole prophylaxis against fungal colonization and infection in preterm infants.
Kaufman, D., Boyle, R., Hazen, K. C., Patrie, J. T., Robinson, M., & Donowitz, L. G. (2001) · New England Journal of Medicine · doi:10.1056/nejmoa010494 · Cited by 523 · cited 1×
“A dose that varies from 3 to 6 mg/kg/dose intravenously or orally every 72 to 48 h has been used effectively for prophylaxis of Candida infections in very-low-birth-weight infants (4, 20, 22).”
MethodShould central venous catheters be removed as soon as candidemia is detected in neonates
Karlowicz, M. G., Hashimoto, L. N., Kelly, R. E., & Buescher, E. S. (2000) · Pediatrics · doi:10.1542/peds.106.5.e63 · Cited by 178
Ophthalmologic, Visceral, and Cardiac Involvement in Neonates with Candidemia
Noyola, D. E., Fernandez, M., Moylett, E. H., & Baker, C. J. (2001) · Clinical Infectious Diseases · doi:10.1086/319601 · Cited by 137 · cited 1×
“Several authors have reported that infants with concurrent fungemia and bacteremia have a higher incidence of endocarditis than infants with fungemia alone (10, 29).”
BackgroundMarchetti, O., Entenza, J. M., Sanglard, D., Bille, J., Glauser, M. P., & Moreillon, P. (2000) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.44.11.2932-2938.2000 · Cited by 113 · cited 1×
“which evaluated serum levels after intraperitoneal administration of fluconazole in adult Wistar rats (25) and whose findings were supported by our pharmacokinetic observations.”
Method
Cited by
Bamford, C. V., d'Mello, A., Nobbs, A. H., Dutton, L. C., Vickerman, M. M., & Jenkinson, H. F. (2009) · Infection and Immunity · doi:10.1128/iai.00438-09 · Cited by 291
“C. albicans may be coisolated with Staphylococcus (67) and with Pseudomonas aeruginosa from other body sites (6, 47).”
Diaz, P. I., Xie, Z., Sobue, T., Thompson, A., Biyikoglu, B., Ricker, A., Ikonomou, L., & Dongari-Bagtzoglou, A. (2012) · Infection and Immunity · doi:10.1128/iai.05896-11 · Cited by 236
“albicans colonization of mucosal surfaces but also during the course of mucosa-associated or invasive infections (8, 58).”
BackgroundXu, H., Sobue, T., Thompson, A., Xie, Z., Poon, K., Ricker, A., Cervantes, J., Diaz, P. I., & Dongari‐Bagtzoglou, A. (2014) · Cellular Microbiology · doi:10.1111/cmi.12216 · Cited by 179
Roux, D., Gaudry, S., Dreyfuss, D., El-Benna, J., de Prost, N., Denamur, E., Saumon, G., & Ricard, J.-D. (2009) · Critical Care Medicine · doi:10.1097/ccm.0b013e31819629d2 · Cited by 129
Metadata
- Authors
- Venkatesh, M. P., Pham, D., Fein, M., Kong, L., & Weisman, L. E.
- Venue
- Antimicrobial Agents and Chemotherapy
- Publisher
- American Society for Microbiology
- Published
- 2007-04
- Volume
- 51
- Issue
- 4
- Pages
- 1240-1245
- ISSN
- 0066-4804 (ISSN-L)
- 1098-6596
- OpenAlex
- W2030468830
- Cited by
- 34
- References
- 4
- FWCI
- 2.15
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Neonatal Coinfection Model of Coagulase-Negative Staphylococcus ( Staphylococcus epidermidis ) and Candida albicans : Fluconazole Prophylaxis Enhances Survival and Growth. https://app.cochat.ai/papers/10.1128/aac.01298-06
- The paper
- Venkatesh, M. P., Pham, D., Fein, M., Kong, L., & Weisman, L. E. (2007). Neonatal Coinfection Model of Coagulase-Negative Staphylococcus ( Staphylococcus epidermidis ) and Candida albicans : Fluconazole Prophylaxis Enhances Survival and Growth. Antimicrobial Agents and Chemotherapy. https://doi.org/10.1128/aac.01298-06
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.